Graphene nanostructures - Theragnostic Technologies
Latest Information Update: 28 Aug 2020
At a glance
- Originator Theragnostic Technologies
- Class Imaging agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Burns; Cardiovascular disorders; Fracture; Wounds
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Burns in USA (Parenteral)
- 28 Aug 2020 No recent reports of development identified for research development in Cardiovascular-disorders in USA (Parenteral)
- 28 Aug 2020 No recent reports of development identified for research development in Fracture in USA (Parenteral)